SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-169726
Filing Date
2023-06-20
Accepted
2023-06-20 09:00:31
Documents
15
Period of Report
2023-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d448184d8k.htm   iXBRL 8-K 34326
2 EX-99.1 d448184dex991.htm EX-99.1 26780
6 GRAPHIC g448184img001.jpg GRAPHIC 9735
7 GRAPHIC g448184img002.jpg GRAPHIC 3286
  Complete submission text file 0001193125-23-169726.txt   213308

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA kdny-20230617.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20230617_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20230617_pre.xml EX-101.PRE 11265
9 EXTRACTED XBRL INSTANCE DOCUMENT d448184d8k_htm.xml XML 3360
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 231023626
SIC: 2834 Pharmaceutical Preparations